Labaran Kamfani
Maganin CAR-T na BIOOCUS Medical Group Dual CD19/BCMA ya samar da sakamako mai kyau a cikin Myasthenia Gravis mai tsauri: Tafiyar Majinyaci Matashi
Nasarar Ilimi | Ƙungiyar Likitoci ta Lu Daopei ta Buga Wani Babban Bincike na Asibiti a cikin Mujallar Haematology ta Burtaniya
Ƙungiyar Likitoci ta Lu Daopei, ƙarƙashin jagorancin Dr. Cao Xingyu da Farfesa Lu Peihua, sun buga wani muhimmin takarda na bincike a fannin lafiya a cikin Mujallar Nazarin Haematology ta Burtaniya (Impact Factor 5.1). Binciken ya binciki aminci da ingancin dashen ƙwayoyin halitta na allogeneic hematopoietic (allo-HSCT) bayan maganin autologous CD7 CAR-T don maganin cutar sankarar lymphoblastic mai saurin kamuwa da cutar T-cell mai saurin kamuwa da cutar sankarar lymphoblastic/lymphoblastic lymphoma (R/R T-ALL/T-LBL).
Nazarin Cibiyoyin Daban-daban Ya Nuna Kyakkyawan Hasashe Ga Marasa Lafiyar Jini Da Ke Yin Dashen Kwayoyin Halittar Allogeneic Tare Da ATG
Wani babban bincike da aka gudanar a wurare da dama a kasar Sin ya nuna sakamako mai kyau ga marasa lafiya da ke fama da cututtukan jini da aka yi wa dashen ƙwayoyin halitta marasa alaƙa da juna (MMUD) tare da ATG don rigakafin GVHD.
Labarin Marasa Lafiya: Babban Hadarin B-ALL, Dashen Maƙogwaro a Watanni 9, Shekaru Biyu Bayan Haka—Farawa Mai Kyau ga Matasan Masoya
An yi wa wani yaro ɗan wata 9 da haihuwa da aka gano yana da cutar Acute B Lymphoblastic Leukemia (B-ALL), tiyatar dashen ƙashi mai kyau. Shekaru biyu bayan haka, yaron yana cikin koshin lafiya kuma a shirye yake ya fara zuwa makarantar yara.
Fahimtar Thalassemia: Jagora Mai Cikakke ga Siffofin Alpha da Beta
Cutar Thalassemia cuta ce da ta fi kowacce cuta. Wannan jagorar ta yi nazari kan alpha da beta thalassemia, musabbabinta, alamominta, da kuma sabbin hanyoyin magani da ake da su a Cibiyar Kiwon Lafiya ta Duniya ta BIOOCUS.
Dr. Lu Peihua Ya Gabatar Da Nasarar Ci Gaba A Fannin Maganin CAR-T A Taron Shekara-shekara na APBMT na 29
A taron shekara-shekara na 29 na Asiya da Pacific na dashen jini da maƙogwaro (APBMT), Dr. Lu Peihua ta gabatar da jawabi mai muhimmanci kan nasarar maganin ƙwayoyin cuta na CAR-T a China. Bayanan ƙungiyarta na zahiri daga ayyukan asibiti sun sami yabo daga ƙasashen duniya, inda suka nuna gudummawar da suka bayar wajen magance cututtukan da ke haifar da cutar jini.
ASH 2024: Ƙungiyar Lu Daopei Ta Nuna Nasarorin Bincike 13 a fannin Ilimin Jini
A taron ASH na 2024 mai zuwa, ƙungiyar likitocin Asibitin Lu Daopei za ta gabatar da sabbin bincike guda 13, waɗanda suka nuna ci gaba a fannin ilimin jini da kuma yuwuwar maganin CAR-T, tare da sake jaddada alƙawarinsu na inganta sakamakon marasa lafiya.
Cin Nasara a Lymphoma tare da Maganin CAR-T Biyu
Bayan ta yi fama da cutar sankarar fata tsawon shekaru uku, wata mata mai shekaru 61 ta sami cikakkiyar sassauci ta hanyar amfani da sabuwar hanyar magance cutar sankarar fata mai suna "CAR-T" a BIOOCUS, wadda ke nuna yiwuwar maganin cutar kansa mai ci gaba da canza rayuwa.
Bioocus Ya Shiga Cikin IGC 2024 Don Binciken Sabbin Hadin Gwiwa Da Tsarin Kasuwanci A Tsarin Immuno-Gene Da Maganin Kwayoyin Halitta
Bioocus yana farin cikin shiga taron Immuno-Gene and Cell Therapy karo na 8 (IGC 2024)! Muna fatan yin aiki tare da kwararru na duniya da kuma binciko sabbin samfuran kasuwanci waɗanda suka dace da fasahar zamani ta maganin kwayoyin halitta da ƙwayoyin halitta. Tare, bari mu tsara makomar maganin rigakafi.
Ingancin Maganin CD7 CAR-T ga Cututtukan B-Cell: Nasara a Maganin Ciwon Daji
Binciken da aka yi kwanan nan ya nuna inganci da amincin maganin ƙwayoyin CD7 CAR-T wajen magance cutar sankarar jini mai saurin kamuwa da cutar B-cell lymphoblastic leukemia (B-ALL) da kuma cutar sankarar lymphoblastic T-cell (T-LBL). Binciken da BIOOCUS ta gudanar tare da haɗin gwiwar Asibitin Lu Daopei, ya nuna sakamako mai kyau ga marasa lafiya, yana ba da madadin maganin chemotherapy na gargajiya.
Ingancin Dogon Lokaci na Maganin Kwayoyin CAR na CD19 wajen Magance Cutar Leukemia Mai Lalacewa/Rage Ragewa
Wani bincike mai zurfi ya nuna nasarar da aka samu na dogon lokaci na maganin ƙwayoyin T-cell na CD19 CAR wajen magance marasa lafiya da suka sake kamuwa da cutar sankarar lymphoblastic mai tsanani (ALL) bayan dashen ƙwayoyin halitta na allogeneic, wanda hakan ke ba da sabon bege a fannin ilimin jini.
Bioocus Ya Ci Gaba Da Yaƙi Wajen Magance Ciwon Leukemia Mai Tsanani Na Yara
Bioocus yana kan gaba wajen haɓaka magungunan CAR-T na zamani. Littafin da Dr. Chunrong Tong da tawagarta suka buga kwanan nan a Asibitin Lu Daopei ya nuna muhimman ci gaba da ƙalubale wajen amfani da magungunan CAR-T na ƙarni na biyu na CD19 ga marasa lafiya na yara, wanda ke nuna jajircewar Bioocus ga maganin cutar kansa mai ƙirƙira.